Literature DB >> 17679066

Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Erick Alexanderson1, Patricio Cruz, Angélica Vargas, Aloha Meave, Alejandro Ricalde, Jose A Talayero, José Luis Romero-Ibarra, Tovë M Goldson, Olga L Vera-Lastra, Gabriela Medina, Luis Jara, Mary-Carmen Amigo.   

Abstract

BACKGROUND: There is limited knowledge about endothelial dysfunction in patients with primary antiphospholipid syndrome (PAPS). The purpose of this study was to evaluate endothelial function in patients with PAPS assessed by positron emission tomography. METHODS AND
RESULTS: A 3-phase protocol--rest, cold pressor test (CPT), and adenosine positron emission tomography with nitrogen 13 ammonia--was used in 18 patients with PAPS and 18 healthy volunteers (HVs). Myocardial blood flow (MBF) was measured in each phase, with calculation of the endothelial-dependent vasodilation index, the increase in the MBF in response to CPT, and the myocardial flow reserve. An important trend was found in the myocardial flow reserve (2.76 +/- 1.04 in PAPS group vs 3.27 +/- 0.72 in HV group, P > .05), in the endothelial-dependent vasodilation index (1.19 +/- 0.31 in PAPS group vs 1.55 +/- 0.37 in HV group, P < .05), and in the percent change in the MBF in response to CPT (from rest) (19% +/- 31% in PAPS group vs 55% +/- 37% in HV group, P < .05).
CONCLUSION: The CPT results obtained in this study showed that the PAPS patients studied have endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679066     DOI: 10.1016/j.nuclcard.2007.05.003

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  42 in total

Review 1.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium.

Authors:  O Amengual; T Atsumi; M A Khamashta
Journal:  Rheumatology (Oxford)       Date:  2003-03-31       Impact factor: 7.580

3.  Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data.

Authors:  M A Barón; M A Khamashta; G R V Hughes; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

4.  Anticardiolipin test and the antiphospholipid (Hughes) syndrome: 20 years and counting!

Authors:  E Nigel Harris; Munther Khamashta
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

Review 5.  Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.

Authors:  John Deanfield; Ann Donald; Claudio Ferri; Cristina Giannattasio; Julian Halcox; Sean Halligan; Amir Lerman; Giuseppe Mancia; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Ernesto L Schiffrin; Stefano Taddei; David J Webb
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

6.  Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.

Authors:  Marcelo F Di Carli; James Janisse; George Grunberger; Joel Ager
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

7.  Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; M di Terlizzi; K P Schäfers; T F Lüscher; P G Camici
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

Review 8.  Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies.

Authors:  Silvia S Pierangeli; Mariano Vega-Ostertag; E Nigel Harris
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

9.  Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease.

Authors:  J L Houghton; M J Frank; A A Carr; T W von Dohlen; L M Prisant
Journal:  J Am Coll Cardiol       Date:  1990-01       Impact factor: 24.094

10.  Early impairment of coronary flow reserve in young men with borderline hypertension.

Authors:  H Laine; O T Raitakari; H Niinikoski; O P Pitkänen; H Iida; J Viikari; P Nuutila; J Knuuti
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  4 in total

1.  Evaluation of the endothelial function in hypertensive patients with 13N-ammonia PET.

Authors:  Erick Alexánderson; Rodrigo Jácome; Moisés Jiménez-Santos; Juan Manuel Ochoa; Edgar Romero; Marco Antonio Peña Cabral; Alejandro Ricalde; Fernando Iñarra; Aloha Meave; Graciela Alexánderson
Journal:  J Nucl Cardiol       Date:  2012-06-12       Impact factor: 5.952

2.  Myocardial function in primary antiphospholipid syndrome using speckle-tracking echocardiography.

Authors:  Gabriela Medina; Eduardo Gómez-Bañuelos; Erick Calderón-Aranda; María Pilar Cruz-Domínguez; Olga Vera-Lastra; Luis J Jara
Journal:  Clin Rheumatol       Date:  2018-04-19       Impact factor: 2.980

3.  Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis.

Authors:  Gian Luca Erre; Giorgio Buscetta; Panagiotis Paliogiannis; Arduino Aleksander Mangoni; Ciriaco Carru; Giuseppe Passiu; Angelo Zinellu
Journal:  Rheumatol Int       Date:  2018-05-07       Impact factor: 2.631

4.  Spontaneous coronary artery dissection presenting as an ischaemic stroke in a middle-aged man with anti-cardiolipin antibodies: a case report.

Authors:  Ns Rajendra; F Lim; N Shaukat
Journal:  J Med Case Rep       Date:  2010-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.